Dr. Kazuhiko Nakagawa Discusses RELAY Study Data, Implications for Practice

Checkpoint Inhibitors in SCLC: Putting the Most Novel Data in Context

Multidisciplinary Tumor Boards: Integrating Best Patient Care and Education in Precision Medicine

Understanding the Promising Role of Stereotactic Ablative Radiotherapy in Treating Patients With Oligometastatic Disease

The Rationale for Local Consolidation Therapy in Oncogene-Driven NSCLC

University of California, Davis, Thoracic Oncology Innovation Group to Again Host Latin American Oncologists for 3-Day Preceptorship 

Cardiac Radiation Dose, Cardiac Events, and Survival in Locally Advanced NSCLC

First Therapeutic Approval in 16 years for MPM

Ending Stigma in Lung Cancer: The IASLC Participates in a Collaborative Summit Held by the National Lung Cancer Roundtable 

Cell-free RNA Affords Another Tool in Lung Cancer Diagnosis and Treatment Monitoring

Supporting the Detection of Early-Stage Disease with Use of Biomarkers